Preliminary evidence suggests that NOTCH2 may contribute to the malignant progression of pancreatic cancer by regulating ferroptosis and promoting an immunosuppressive tumor microenvironment. This evidence concerns the gene NOTCH2 and familial pancreatic carcinoma.